Careers at EarliPoint Health

Helping children. Supporting families. Driving innovation.

Study Locations

Join the EarliPoint Team

At EarliPoint Health, our mission is clear: to transform early diagnosis and ongoing assessment with science-driven, clinically validated technology. We believe that earlier insights create brighter futures—for children, families, and providers alike.

Why Work With Us

  • Meaningful Impact – Every role at EarliPoint contributes to making life-changing diagnostics accessible to more families.
  • Collaborative Culture – We bring together clinicians, scientists, engineers, and innovators to push boundaries and share knowledge.
  • Growth Opportunities – As a fast-growing organization, we offer room to learn, lead, and make your mark.
  • Shared Purpose – Our team is united by a personal and professional commitment to advancing early childhood care.

No Current Openings

We’re not actively hiring right now, but we’re always eager to connect with talented individuals who share our mission. If you’d like to be considered for future opportunities, please fill out the form below.

Jamie Pagliaro brings over two decades of leadership in autism and behavioral health to his role as President and CEO of EarliPoint. Most recently, he served as Chief Operating Officer at Rethink, a leading SaaS provider supporting individuals with autism and developmental disabilities. Under his leadership, Rethink’s behavioral health division became the company’s largest business unit, serving thousands of clinicians and driving scalable, tech-enabled care delivery.

Earlier in his career, Jamie was Executive Director of the New York Center for Autism Charter School, the first public charter school in New York State dedicated to children with autism. At EarliPoint, he leads the company’s mission to bring breakthrough science to the front lines of care—empowering providers, families, and health systems with earlier answers and better outcomes.

Jamie Pagliaro

President & Chief Executive Officer

Dr. Ami Klin is a globally recognized leader in autism research and early detection. As Director of the Marcus Autism Center and Division Chief of Autism and Developmental Disabilities at Emory University School of Medicine, he has dedicated his career to understanding how young children engage with the social world—and how subtle disruptions in attention can signal developmental differences. His pioneering work in eye-tracking science led to the development of EarliPoint™ Evaluation, the first FDA-authorized tool to objectively assess autism in children as young as 16 months.
At EarliPoint, Dr. Klin drives clinical strategy and innovation, ensuring that families and clinicians worldwide have access to timely, science-based insights that enable earlier, more personalized intervention. His career reflects a deep commitment to transforming how society supports children with autism—starting with the earliest signs.

Ami Klin, PhD

Chief Clinical Officer & Co‑Founder